ATTMULTI

Welcome to the Brand page for “ATTMULTI”, which is offered here for Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of lennox-gastaut syndrome (lgs), sclerosis, porphyria, huntington's disorder and disease, insomnia, parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, adhd, ptsd, agitation, aggression, autism, melancholy, ocd, tourette's syndrome, progressive supranuclear palsy (psp); pharmaceutical preparations and substances for the prevention and treatment of restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “ATTMULTI” is believed to be currently owned by “H. Lundbeck A/S”.